Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $339.77 million versus the consensus estimate of $334.75 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2024 EPS of $0.08-$0.12, versus the consensus of $0.17. Cross Country Healthcare sees Q3 2024 revenue of $305-315 million, versus the consensus of $330.9 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.